BR9508468A - Compound process for the preparation of the same pharmaceutical composition processes for the treatment and / or prophylaxis of hyperglycemia in a human or non-human mammal and for the treatment of hyperlipidemia hypertension cardiovascular disease some eating disorders the treatment and / or prophylaxis of kidney disease prevention revers o stabilization or retardation of microalbuminuria progression in a human or non-human mammal use of the compound and intermediate compound - Google Patents
Compound process for the preparation of the same pharmaceutical composition processes for the treatment and / or prophylaxis of hyperglycemia in a human or non-human mammal and for the treatment of hyperlipidemia hypertension cardiovascular disease some eating disorders the treatment and / or prophylaxis of kidney disease prevention revers o stabilization or retardation of microalbuminuria progression in a human or non-human mammal use of the compound and intermediate compoundInfo
- Publication number
- BR9508468A BR9508468A BR9508468A BR9508468A BR9508468A BR 9508468 A BR9508468 A BR 9508468A BR 9508468 A BR9508468 A BR 9508468A BR 9508468 A BR9508468 A BR 9508468A BR 9508468 A BR9508468 A BR 9508468A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- human
- compound
- prophylaxis
- human mammal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9415330A GB9415330D0 (en) | 1994-07-29 | 1994-07-29 | Novel compounds |
| GBGB9425599.9A GB9425599D0 (en) | 1994-12-19 | 1994-12-19 | Novel compounds |
| GBGB9509923.0A GB9509923D0 (en) | 1995-05-17 | 1995-05-17 | Novel compounds |
| PCT/GB1995/001323 WO1996004261A1 (en) | 1994-07-29 | 1995-06-07 | Benzoxazoles and pryridine derivatives useful in the treatment of the type ii diabetes |
| PCT/EP1995/003038 WO1996004260A1 (en) | 1994-07-29 | 1995-07-28 | Benzoxazoles and pyridine derivatives useful in the treatment of the type ii diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9508468A true BR9508468A (en) | 1997-11-25 |
Family
ID=27267309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9508468A BR9508468A (en) | 1994-07-29 | 1995-06-07 | Compound process for the preparation of the same pharmaceutical composition processes for the treatment and / or prophylaxis of hyperglycemia in a human or non-human mammal and for the treatment of hyperlipidemia hypertension cardiovascular disease some eating disorders the treatment and / or prophylaxis of kidney disease prevention revers o stabilization or retardation of microalbuminuria progression in a human or non-human mammal use of the compound and intermediate compound |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0772605A1 (en) |
| AP (1) | AP776A (en) |
| BR (1) | BR9508468A (en) |
| CA (1) | CA2196079A1 (en) |
| CZ (1) | CZ25497A3 (en) |
| DZ (1) | DZ1916A1 (en) |
| FI (1) | FI970357L (en) |
| HU (1) | HUT76637A (en) |
| IL (3) | IL125525A (en) |
| MA (1) | MA23632A1 (en) |
| MX (1) | MX9700763A (en) |
| NO (1) | NO307827B1 (en) |
| OA (1) | OA10470A (en) |
| PL (1) | PL318766A1 (en) |
| SK (1) | SK12297A3 (en) |
| WO (2) | WO1996004261A1 (en) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9600464D0 (en) * | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
| CZ318098A3 (en) * | 1996-04-04 | 1999-01-13 | Sankyo Company, Limited | Derivatives of phenylalkylcarboxylic acid, process of their preparation and pharmaceutical composition containing thereof |
| US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
| US6160000A (en) * | 1996-12-23 | 2000-12-12 | Merck & Co., Inc. | Antidiabetic agents based on aryl and heteroarylacetic acids |
| TR200000896T2 (en) | 1997-10-02 | 2000-09-21 | Sankyo Company Limited | Amidocarboxylic acid derivatives. |
| US6440961B1 (en) | 1997-10-27 | 2002-08-27 | Dr. Reddy's Research Foundation | Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| US6444816B1 (en) | 1997-10-27 | 2002-09-03 | Dr. Reddy's Research Foundation | Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof |
| US6369067B1 (en) | 1997-10-27 | 2002-04-09 | Dr. Reddy's Research Foundation | Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| KR100517644B1 (en) * | 1997-10-27 | 2005-09-28 | 닥터 레디스 레보러터리즈 리미티드 | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| WO1999019313A1 (en) * | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| US6265401B1 (en) | 1997-10-27 | 2001-07-24 | Reddy-Cheminor, Inc. | Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| RU2247722C2 (en) | 1997-10-27 | 2005-03-10 | Др. Редди`З Лабораториз Лимитед | Derivatives of aryl carboxylic acids, methods for their preparing, pharmaceutical composition based on thereof, methods for treatment and prophylaxis of different diseases, intermediate compounds and methods for their preparing |
| WO1999016758A1 (en) | 1997-10-27 | 1999-04-08 | Dr. Reddy's Research Foundation | Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| CN100357281C (en) * | 1998-05-27 | 2007-12-26 | 雷迪实验室有限公司 | Bicyclic compounds, process for their preparation and pharmaceutical composition containing them |
| BR9913831A (en) | 1998-09-17 | 2001-05-29 | Bristol Myers Squibb Co | Process for the treatment of arteriosclerosis using an ap2 inhibitor and combination |
| US6468996B1 (en) | 1998-10-21 | 2002-10-22 | Novo Nordisk A/S | Substituted hetero-polycyclic compounds as PPARα and PPARγ activators |
| US6214820B1 (en) | 1998-10-21 | 2001-04-10 | Novo Nordisk A/S | Compounds, their preparation and use |
| EP1123292A1 (en) * | 1998-10-21 | 2001-08-16 | Novo Nordisk A/S | New compounds, their preparation and use |
| US6300339B1 (en) | 1998-10-21 | 2001-10-09 | Novo Nordisk A/S | Compounds, their preparation and use |
| JP2002527520A (en) * | 1998-10-21 | 2002-08-27 | ノボ ノルディスク アクティーゼルスカブ | New compounds, their production and use |
| WO2000023417A1 (en) * | 1998-10-21 | 2000-04-27 | Novo Nordisk A/S | New compounds, their preparation and use |
| WO2000023416A1 (en) * | 1998-10-21 | 2000-04-27 | Novo Nordisk A/S | New compounds, their preparation and use |
| EP1123279A1 (en) * | 1998-10-21 | 2001-08-16 | Novo Nordisk A/S | New compounds, their preparation and use |
| WO2000023415A1 (en) | 1998-10-21 | 2000-04-27 | Novo Nordisk A/S | New compounds, their preparation and use |
| US6365586B1 (en) | 1998-10-21 | 2002-04-02 | Novo Nordisk A/S | Compounds, their preparation and use |
| US6248781B1 (en) | 1998-10-21 | 2001-06-19 | Novo Nordisk A/S | Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR) |
| EP1124808A1 (en) * | 1998-10-29 | 2001-08-22 | Dr. Reddy's Research Foundation | An improved process for the preparation of new antidiabetic agents |
| US6531596B1 (en) | 1998-10-29 | 2003-03-11 | Dr. Reddy's Laboratories Ltd. | Process for the preparation of new antidiabetic agents |
| WO2000063193A1 (en) * | 1999-04-16 | 2000-10-26 | Dr. Reddy's Research Foundation | Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them |
| PL351312A1 (en) * | 1999-04-20 | 2003-04-07 | Novo Nordisk As | New compounds, their preparation and use |
| US6972294B1 (en) | 1999-04-20 | 2005-12-06 | Novo Nordisk, A/S | Compounds, their preparation and use |
| US7414128B2 (en) | 1999-04-20 | 2008-08-19 | Dr. Reddy's Laboratories, Limited | Crystalline R-guanidines, Arginine or (L)-Arginine (2S)-2-Ethoxy-3-{4-[2-(10H -phenoxazin-10-yl)ethoxy]phenyl}propanoate |
| JP2002542237A (en) * | 1999-04-20 | 2002-12-10 | ノボ ノルディスク アクティーゼルスカブ | New compounds, their production and use |
| US6369055B1 (en) | 1999-04-20 | 2002-04-09 | Novo Nordisk A/S | Compounds, their preparation and use |
| AU3958100A (en) | 1999-04-20 | 2000-11-02 | Novo Nordisk A/S | New compounds, their preparation and use |
| US6274608B1 (en) | 1999-04-20 | 2001-08-14 | Novo Nordisk A/S | Compounds, their preparation and use |
| CA2371757A1 (en) * | 1999-04-28 | 2000-11-09 | Dr. Reddy's Research Foundation | Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| CA2382966A1 (en) | 1999-08-27 | 2001-03-08 | Eli Lilly And Company | Biaryl-oxa(thia)zole derivatives and their use as ppars modulators |
| EP1250323B1 (en) * | 2000-01-19 | 2014-01-01 | Cadila Healthcare Limited | Compounds having hypolipidemic and hypocholesterolemic activities, process for their preparation and pharmaceutical compositions containing them |
| US6555577B1 (en) | 2000-01-28 | 2003-04-29 | Novo Nordisk A/S | Compounds, their preparation and use |
| US6569901B2 (en) | 2000-01-28 | 2003-05-27 | Novo Nordisk A/S | Alkynyl-substituted propionic acid derivatives, their preparation and use |
| BR0107902A (en) * | 2000-01-28 | 2002-11-05 | Novo Nordisk As | Compound, pharmaceutical composition, methods for treating diseases, and for the treatment and / or prevention of, conditions mediated by nuclear receptors, and diabetes and / or obesity, use of a compound, process for preparing a compound, and, method for treating type i diabetes, type ii diabetes, impaired glucose tolerance, insulin resistance or obesity |
| US6509374B2 (en) | 2000-04-17 | 2003-01-21 | Novo Nordisk A/S | Compounds, their preparation and use |
| AU2001261503A1 (en) * | 2000-05-12 | 2001-11-26 | Ortho-Mcneil Pharmaceutical, Inc. | Methods of treatment using benzoxazinones as peroxisome proliferator activated receptor gamma modulators |
| EP1280782A2 (en) * | 2000-05-12 | 2003-02-05 | Ortho-McNeil Pharmaceutical, Inc. | Novel benzoxazinones as peroxisome proliferator activated receptor gamma modulators and method of treatment |
| US6555536B2 (en) | 2000-05-12 | 2003-04-29 | Ortho-Mcneil Pharmaceutical, Inc. | Biologically active 4H-benzo [1,4]oxazin-3-ones |
| US6908908B2 (en) | 2000-05-12 | 2005-06-21 | Ortho-Mcneil Pharmaceutical, Inc. | Biologically active 4H-benzo [1,4] oxazin-3-ones |
| US6987123B2 (en) * | 2001-07-26 | 2006-01-17 | Cadila Healthcare Limited | Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| US6869967B2 (en) | 2001-07-30 | 2005-03-22 | Novo Nordisk A/S | Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives |
| US7067530B2 (en) | 2001-07-30 | 2006-06-27 | Novo Nordisk A/S | Compounds, their preparation and use |
| US7220877B2 (en) | 2001-10-17 | 2007-05-22 | Novo Nordisk A/S | Compounds, their preparation and use |
| AU2002351752A1 (en) | 2001-12-29 | 2003-07-30 | Novo Nordisk A/S | Combined use of a glp-1 compound and another drug for treating dyslipidemia |
| US7015345B2 (en) | 2002-02-21 | 2006-03-21 | Asahi Kasei Pharma Corporation | Propionic acid derivatives |
| US7816385B2 (en) | 2002-12-20 | 2010-10-19 | High Point Pharmaceuticals, Llc | Dimeric dicarboxylic acid derivatives, their preparation and use |
| US6653334B1 (en) | 2002-12-27 | 2003-11-25 | Kowa Co., Ltd. | Benzoxazole compound and pharmaceutical composition containing the same |
| US20100274022A1 (en) * | 2007-04-26 | 2010-10-28 | Pharmafrontier Co., Ltd. | G protein-coupled receptor inhibitor and pharmaceutical product |
| RS54735B1 (en) | 2011-01-31 | 2016-10-31 | Cadila Healthcare Ltd | LIPODYSTROPHY TREATMENT |
| KR101617812B1 (en) | 2013-04-22 | 2016-05-03 | 카딜라 핼쓰캐어 리미티드 | A novel composition for nonalcoholic fatty liver disease |
| US20160107989A1 (en) | 2013-05-30 | 2016-04-21 | Cadila Healthcare Limited | A process for preparation of pyrroles having hypolipidemic hypocholesteremic activities |
| TW201513857A (en) | 2013-07-05 | 2015-04-16 | Cadila Healthcare Ltd | Synergistic compositions |
| IN2013MU02470A (en) | 2013-07-25 | 2015-06-26 | Cadila Healthcare Ltd | |
| WO2015033357A2 (en) | 2013-09-06 | 2015-03-12 | Cadila Healthcare Limited | An improved process for the preparation of pyrrole derivatives |
| WO2017064635A2 (en) | 2015-10-14 | 2017-04-20 | Cadila Healthcare Limited | Pyrrole compound, compositions and process for preparation thereof |
| MX382765B (en) | 2016-12-09 | 2025-03-13 | Zydus Lifesciences Ltd | TREATMENT FOR PRIMARY BILIARY CHOLANGITIS. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5089514A (en) * | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
| RU2134686C1 (en) * | 1992-07-03 | 1999-08-20 | Смитклайн Бичам П.Л.С. | Heterocyclic compound or its tautomeric form and/or pharmaceutically acceptable salt and/or pharmaceutically acceptable solvate, pharmaceutical composition decreasing blood glucose level, method of treatment and/or prophylaxis of hypoglycemic patients |
-
1995
- 1995-06-07 BR BR9508468A patent/BR9508468A/en unknown
- 1995-06-07 WO PCT/GB1995/001323 patent/WO1996004261A1/en not_active Ceased
- 1995-07-26 DZ DZ950094A patent/DZ1916A1/en active
- 1995-07-27 IL IL12552595A patent/IL125525A/en unknown
- 1995-07-27 MA MA23972A patent/MA23632A1/en unknown
- 1995-07-27 IL IL11475995A patent/IL114759A/en unknown
- 1995-07-28 CA CA002196079A patent/CA2196079A1/en not_active Abandoned
- 1995-07-28 PL PL95318766A patent/PL318766A1/en unknown
- 1995-07-28 AP APAP/P/1997/000918A patent/AP776A/en active
- 1995-07-28 HU HU9700264A patent/HUT76637A/en unknown
- 1995-07-28 CZ CZ97254A patent/CZ25497A3/en unknown
- 1995-07-28 FI FI970357A patent/FI970357L/en unknown
- 1995-07-28 MX MX9700763A patent/MX9700763A/en unknown
- 1995-07-28 EP EP95930436A patent/EP0772605A1/en not_active Withdrawn
- 1995-07-28 SK SK122-97A patent/SK12297A3/en unknown
- 1995-07-28 WO PCT/EP1995/003038 patent/WO1996004260A1/en not_active Ceased
-
1997
- 1997-01-28 NO NO970373A patent/NO307827B1/en not_active IP Right Cessation
- 1997-01-29 OA OA60957A patent/OA10470A/en unknown
-
1998
- 1998-07-27 IL IL12552598A patent/IL125525A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ25497A3 (en) | 1997-09-17 |
| CA2196079A1 (en) | 1996-02-15 |
| FI970357A0 (en) | 1997-01-28 |
| EP0772605A1 (en) | 1997-05-14 |
| NO307827B1 (en) | 2000-06-05 |
| MA23632A1 (en) | 1996-04-01 |
| DZ1916A1 (en) | 2002-02-17 |
| MX9700763A (en) | 1997-05-31 |
| WO1996004260A1 (en) | 1996-02-15 |
| WO1996004261A1 (en) | 1996-02-15 |
| FI970357A7 (en) | 1997-03-26 |
| IL114759A0 (en) | 1995-12-31 |
| FI970357L (en) | 1997-03-26 |
| HUT76637A (en) | 1997-10-28 |
| NO970373D0 (en) | 1997-01-28 |
| IL125525A (en) | 2000-02-29 |
| NO970373L (en) | 1997-03-18 |
| IL125525A0 (en) | 1999-03-12 |
| IL114759A (en) | 1999-10-28 |
| AP9700918A0 (en) | 1997-01-31 |
| PL318766A1 (en) | 1997-07-07 |
| AP776A (en) | 1999-10-28 |
| OA10470A (en) | 2002-04-08 |
| SK12297A3 (en) | 1997-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9508468A (en) | Compound process for the preparation of the same pharmaceutical composition processes for the treatment and / or prophylaxis of hyperglycemia in a human or non-human mammal and for the treatment of hyperlipidemia hypertension cardiovascular disease some eating disorders the treatment and / or prophylaxis of kidney disease prevention revers o stabilization or retardation of microalbuminuria progression in a human or non-human mammal use of the compound and intermediate compound | |
| BR9609467A (en) | Compound use of a compound Pharmaceutical composition and processes for preparing a compound and treating plank aggregation disorders | |
| BR9406128A (en) | Use of a process compound for the treatment and / or prevention of psychotic disorders compound pharmaceutical composition processes for the preparation of a compound and a pharmaceutical composition | |
| BR9507788A (en) | Compound or solvate or salt of the same process for the preparation of the compound pharmaceutical composition NK3 receptor antagonist use of the compound use of the NG3 receptor antagonist and process for the treatment and / or prophylaxis of pulmonary disorders and seizure disorders | |
| PT98944A (en) | PROCESS FOR THE PREPARATION OF ALTERED ANTIBODIES AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFECTIONS | |
| BR9708607A (en) | Compound pharmaceutical composition use of a compound process for treating or reducing the risk of inflammatory disease in a patient and for the preparation of a compound and chemical intermediate | |
| BR9506473A (en) | Compound process for the preparation of compounds use of a compound pharmaceutical composition and process for the treatment of anti-fungal infections | |
| BR9600487A (en) | Use of at least one cgrp antagonist use of at least one cgrp antagonist in a topical composition cosmetic treatment process and composition | |
| BR9504509A (en) | Compound process for its preparation and pharmaceutical formulation | |
| BR9404203A (en) | Compounds, process for their preparation, medication, use of said compounds and process for the treatment or prevention of central nervous disorders | |
| BR9506026A (en) | Pearls of controlled release process for the preparation of the same pharmaceutical preparation process for the manufacture of the same use of pearls of controlled release and process for the treatment of edema hypertension and congestive heart failure | |
| BR9505107A (en) | Compound pharmaceutical composition process for the preparation of a compound and its use | |
| BR9204361A (en) | COMPOUND AND PROCESS FOR ITS PREPARATION PHARMACEUTICAL AND INTERMEDIATE FORMULATION | |
| BR9506581A (en) | Compound pharmaceutical composition use of the process compound for the prophylaxis or treatment of a clinical condition in a manifer for example a human and for the preparation of a compound and intermediate compound | |
| BR9711311A (en) | Compound pharmaceutical composition use of a compound and processes for the preparation of compounds and for the treatment of a mammal including man | |
| BR9607346A (en) | Compound use of a compound, pharmaceutical composition and process for the treatment of a mammal and for and preparation of compounds | |
| BR9510102A (en) | Peptide use of the same process to diagnose the presence or onset of insulin-dependent diabetes mellitus in a patient kit to diagnose the presence of insulin-dependent diabetes mellitus preparation and process for the prevention or treatment of insulin-dependent mellitus disorders and pharmaceutical composition | |
| BR9201017A (en) | TISSUE SOFTENING COMPOSITION AND PROCESS FOR ITS PREPARATION | |
| BR9708093A (en) | Compound compound use formulation and process for treating 5-hydroxytryptamine-mediated disorders and for compound preparation | |
| BR9604031A (en) | Use of at least one compound chosen from bradykinin antagonists use in a topical composition of at least one compound chosen from bradykin antagonists cosmetic treatment process and cosmetic pharmaceutical or dermatological composition | |
| BR9206950A (en) | Pharmaceutical composition and process for its preparation | |
| BR9610733A (en) | Compound processes for the preparation of it and for the treatment of a mammal pharmaceutical composition and use of a compound | |
| BR1100524A (en) | Compounds, process for their preparation; intermediate compounds therefor, and pharmaceutical compositions | |
| BR9406923A (en) | Compounds derived from (1-heteroazolyl-1-heterocyclyl) alkane process to prepare the same pharmaceutical formulation use of compounds and process for the treatment of chronic and acute neuropsychiatric disorders | |
| BR9202446A (en) | DENTIFICATION COMPOSITION, DENTIFICATION AND PROCESS FOR THE PREPARATION OF A DENTIFICATION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |